News

Pfizer’s $1.5B cuts; Biogen’s $1.15B buyout; AstraZeneca’s $80B ambition; RNA startup merger; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up […]

No Picture
San Diego Biotech Jobs

Research Associate -Preclinical in vivo imaging and therapeutic studies – PRISM – Proteogenomics Research Institute for Systems Medicine – La Jolla, CA

Intravenous administration of imaging reagents in mice and rats and performing in vivo imaging studies using IVIS system for imaging… Click here to view original post

News

Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep’s Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action

Trial-in-progress abstract highlights new cohort that could expand the company’s pancreatic cancer program Pelareorep’s ability to expand TILs highlights its immunotherapeutic mechanism of action and potential as a backbone immunotherapy for multiple indications SAN DIEGO […]

No Picture
News

Medtronic study shows navigated bronchoscopy can avoid needle biopsy complications in diagnoses of lung cancer

A head-to-head study from Medtronic showed that its minimally invasive approach to reaching tissues in the lung suspected of harboring cancer could be just as effective as the current standard of care biopsy—which requires guiding […]

News

Biossmann Snags AI Thought-Leader Pankaj Kedia as its First Chief AI Officer and Board Member to Fuel the Next Phase of Growth

Sets groundwork for global expansion and transformation into a medical solutions powerhouse with AI-based innovations MEXICO CITY and SAN DIEGO, May 23, 2024 /PRNewswire/ — Biossmann today announced that it is bringing on board renowned […]

BioSpace

Takeda Joins Hot Molecular Glue Market With $1.2B Deal

Published: May 23, 2024 By Tristan Manalac Pictured: Facade of Takeda’s office in Massachusetts/iStock, hapabapa Takeda Pharmaceuticals has inked an exclusive licensing deal with China-based Degron Therapeutics to develop novel molecular glue degraders for various […]

News

New data from the Phase 3 NEURO-TTRansform study evaluating WAINUA™ (eplontersen) to be presented at the 2024 International Symposium on Amyloidosis (ISA)

– Results across NEURO-TTRansform subgroups show consistent benefit in neuropathy impairment and improved quality of life, regardless of patient segmentation – CARLSBAD, Calif., May 23, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today […]

No Picture
News

Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference

St Andrews, UK – 23nd May 2024 – Pneumagen, a clinical stage biotech company developing Neumifil (HEX17), a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs), presented positive […]